Breast cancer (BC) is a clinically heterogeneous disease encompassing about 15 different types of carcinomas, sub-classified according to their estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) status [1]. This evidence concerns the gene ERBB2 and carcinoma.